Founded in January 2022, BayOmics is an innovative high-tech enterprise focusing on proteomics. BayOmics is committed to continuously innovating proteomics technologies to drive disease diagnosis and innovative drug discovery, creating a new era of clinical functional proteomics in the nano era.
Proteomics research brings unprecedented scientific insights to the life sciences. Pepto Bio will continue to promote the innovative development of proteomics technology, provide more innovative proteomics research tools accessible to everyone, and help scientists around the world to make significant contributions to the development of human health.
BayOmics adheres to the tenet of science and innovation. Relying on our exclusive patented proteomics pre-processing technology (SISPROT), we provide diversified scientific research services, reagent kit products, instrument platforms and total solutions, including nano-scale proteomics, high-depth spatial visualization proteomics, and clinical functional proteomics, etc., which are mainly applied to tissue microenvironment analysis, biomarker development, and discovery of innovative drug targets, accelerating the Disease diagnosis and development of precision medicine.
Official Account
